252 related articles for article (PubMed ID: 32432647)
1. Disease Trajectories for Hidradenitis Suppurativa in the Danish Population.
Kjærsgaard Andersen R; Jørgensen IF; Reguant R; Jemec GBE; Brunak S
JAMA Dermatol; 2020 Jul; 156(7):780-786. PubMed ID: 32432647
[TBL] [Abstract][Full Text] [Related]
2. Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa.
Jørgensen AR; Aarestrup J; Baker JL; Thomsen SF
JAMA Dermatol; 2020 Jul; 156(7):746-753. PubMed ID: 32347905
[TBL] [Abstract][Full Text] [Related]
3. Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa.
Egeberg A; Gislason GH; Hansen PR
JAMA Dermatol; 2016 Apr; 152(4):429-34. PubMed ID: 26885728
[TBL] [Abstract][Full Text] [Related]
4. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents.
Tiri H; Jokelainen J; Timonen M; Tasanen K; Huilaja L
J Am Acad Dermatol; 2018 Sep; 79(3):514-519. PubMed ID: 29518461
[TBL] [Abstract][Full Text] [Related]
5. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Jemec GBE; Garg A
JAMA Dermatol; 2020 Jan; 156(1):65-71. PubMed ID: 31721983
[TBL] [Abstract][Full Text] [Related]
7. Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Garg A
JAMA Dermatol; 2019 Jul; 155(7):797-802. PubMed ID: 30994865
[TBL] [Abstract][Full Text] [Related]
8. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study.
Krajewski PK; Matusiak Ł; Ständer S; Thaçi D; Szepietowski JC; Zirpel H
Int J Dermatol; 2024 Jun; 63(6):799-805. PubMed ID: 38644522
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients.
Kittler NW; Williams JC; Kudlinski MV; Lester J; Hills N; Abuabara K; Naik HB
JAMA Dermatol; 2022 Dec; 158(12):1404-1408. PubMed ID: 36287577
[TBL] [Abstract][Full Text] [Related]
10. Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins.
Kjaersgaard Andersen R; Clemmensen SB; Larsen LA; Hjelmborg JVB; Ødum N; Jemec GBE; Christensen K
Br J Dermatol; 2022 Jan; 186(1):78-85. PubMed ID: 34289077
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
[TBL] [Abstract][Full Text] [Related]
12. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
Kirby JS; Miller JJ; Adams DR; Leslie D
JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study.
Theut Riis P; Pedersen OB; Sigsgaard V; Erikstrup C; Paarup HM; Nielsen KR; Burgdorf KS; Hjalgrim H; Rostgaard K; Banasik K; Ullum H; Jemec GB
Br J Dermatol; 2019 Apr; 180(4):774-781. PubMed ID: 29999187
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
Killasli H; Sartorius K; Emtestam L; Svensson Å
Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
[TBL] [Abstract][Full Text] [Related]
15. Increased cancer incidence among patients with hidradenitis suppurativa - a Danish nationwide register study 1977-2017.
Andersen R; Rostgaard K; Pedersen O; Jemec GBE; Hjalgrim H
Acta Oncol; 2024 Apr; 63():220-228. PubMed ID: 38647025
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis as a comorbidity of hidradenitis suppurativa.
Kjaersgaard Andersen R; Saunte SK; Jemec GBE; Saunte DM
Int J Dermatol; 2020 Feb; 59(2):216-220. PubMed ID: 31591714
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
18. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
19. Association of Psychiatric and Neurologic Comorbidity With Mortality Among Persons With Autism Spectrum Disorder in a Danish Population.
Schendel DE; Overgaard M; Christensen J; Hjort L; Jørgensen M; Vestergaard M; Parner ET
JAMA Pediatr; 2016 Mar; 170(3):243-50. PubMed ID: 26752506
[TBL] [Abstract][Full Text] [Related]
20. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
